Location San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Female
LinkedIn View on LinkedIn
Dr. Grace Colón brings over 25 years of experience in biopharma, genomics, healthcare and industrial biotechnology. Her executive roles have spanned a broad range of functions in companies ranging from start-ups to publicly traded corporations. In addition to her role at InCarda, she serves on the board of directors of ProterixBio (Executive
Chairman; formerly CEO), CareDx (NASDAQ:CDNA) and Cocoon Biotech, and formerly on the boards of Paradigm Diagnostics and PerceptiMed. She was also formerly a Partner and Senior Advisor at New Science Ventures, a NY-based venture capital firm with over $700M under management, and held executive and managerial roles at Intrexon Corporation, Gilead Sciences, Affymetrix, the International Genomics Consortium and McKinsey & Co. Dr. Colón received her Ph.D. from the Massachusetts Institute of Technology and a B.S. degree from the University of Pennsylvania, both in chemical engineering.
